microbiota of IBD patients
gut-microbiota interface
intestinal microbiota
altered gut microbiota
understanding of IBD
IBD results
incidence of IBD
Card9 signalling
metabolic activity
Modulation
IBD susceptibility genes
host-bacteria interface
host-bacteria crosstalk
health
new preventive
AhR receptors
new pathways
impaired production of AhR ligands
Inflammatory Bowel Diseases
new key skills
increased susceptibility
comparable mechanisms
microbial community
cutting-edge techniques
gnotobiotic animals
cre-lox technology
transcriptomics
numerous pathologies
aryl hydrocarbon receptor
combination of genetic predisposition
human intestine
strong collaborative environment
lives
metabolomics
complex ecosystem
protein
tryptophan
colitis
alteration
technical knowledge
fragile balance
advantage
individuals
cell types
mice
microorganisms
codes
metabolites
immunosuppressive treatments
challenging years
systems biology
scientific network
therapeutic strategies
response
fungi
Caspase recruitment domain
nutrition
environmental influences
integrative project
Loss
humans
Sokol
colleagues
purpose
genotype